La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

K-One Technology Berhad Salute del bilancio

Salute finanziaria criteri di controllo 6/6

K-One Technology Berhad ha un patrimonio netto totale di MYR118.2M e un debito totale di MYR0.0, che porta il suo rapporto debito/patrimonio netto a 0%. Le sue attività totali e le sue passività totali sono rispettivamente MYR176.4M e MYR58.1M.

Informazioni chiave

Rapporto debito/patrimonio netto

RM 0

Debito

Indice di copertura degli interessi	n/a
Contanti	RM 46.90m
Patrimonio netto	RM 118.25m
Totale passività	RM 58.13m
Totale attività	RM 176.37m

Aggiornamenti recenti sulla salute finanziaria

We Think K-One Technology Berhad (KLSE:K1) Can Easily Afford To Drive Business Growth

May 09

We're Not Very Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Rate

Oct 26

Here's Why We're Not Too Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Situation

Jun 13

We're Not Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn

Feb 07

We're Hopeful That K-One Technology Berhad (KLSE:K1) Will Use Its Cash Wisely

Oct 05

Recent updates

Optimistic Investors Push K-One Technology Berhad (KLSE:K1) Shares Up 75% But Growth Is Lacking

Jul 12

K-One Technology Berhad's (KLSE:K1) 28% Share Price Surge Not Quite Adding Up

May 27

A Look At The Intrinsic Value Of K-One Technology Berhad (KLSE:K1)

Nov 03

We Think K-One Technology Berhad (KLSE:K1) Can Easily Afford To Drive Business Growth

May 09

We're Not Very Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Rate

Oct 26

Here's Why We're Not Too Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Situation

Jun 13

Key Things To Understand About K-One Technology Berhad's (KLSE:K1) CEO Pay Cheque

Nov 30

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( MYR124.5M ) di K1 superano le sue passività a breve termine ( MYR57.7M ).

Passività a lungo termine: Le attività a breve termine di K1 ( MYR124.5M ) superano le sue passività a lungo termine ( MYR392.0K ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: K1 è esente da debiti.

Riduzione del debito: K1 non ha debiti rispetto a 5 anni fa, quando il suo rapporto debito/patrimonio netto era 0.7%.

Copertura del debito: K1 non ha debiti, pertanto non deve essere coperto dal flusso di cassa operativo.

Copertura degli interessi: K1 non ha debiti, pertanto la copertura dei pagamenti degli interessi non è un problema.

K-One Technology Berhad Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

We Think K-One Technology Berhad (KLSE:K1) Can Easily Afford To Drive Business Growth

We're Not Very Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Rate

Here's Why We're Not Too Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Situation

We're Not Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn

We're Hopeful That K-One Technology Berhad (KLSE:K1) Will Use Its Cash Wisely

Recent updates

Optimistic Investors Push K-One Technology Berhad (KLSE:K1) Shares Up 75% But Growth Is Lacking

K-One Technology Berhad Announces Resignation of Wong Youn Kim as Company Secretary

First quarter 2024 earnings released: EPS: RM0.002 (vs RM0.001 loss in 1Q 2023)

K-One Technology Berhad's (KLSE:K1) 28% Share Price Surge Not Quite Adding Up

K-One Technology Berhad, Annual General Meeting, Jun 19, 2024

New major risk - Revenue and earnings growth

K-One Technology Berhad Appoints Wong Mee Kiat as Joint Secretary

Full year 2023 earnings released: EPS: RM0 (vs RM0 in FY 2022)

Third quarter 2023 earnings released: RM0.002 loss per share (vs RM0.002 profit in 3Q 2022)

New minor risk - Share price stability

A Look At The Intrinsic Value Of K-One Technology Berhad (KLSE:K1)

Now 20% undervalued after recent price drop

K-One Meditech Sdn Bhd Receives Approval from the Medical Device Authority Under the Ministry of Health, Malaysia for Registration of Diversey's Oxivir Excel Disinfectant Wipes Used for Cleaning Surfaces and Equipment

Second quarter 2023 earnings released: EPS: RM0 (vs RM0.003 loss in 2Q 2022)

First quarter 2023 earnings released: EPS: RM0 (vs RM0.001 in 1Q 2022)

K-One Technology Berhad Announces Cessation of Office of Loi Kim Fah as Independent and Non Executive Chairman of Risk Committee

K-One Technology Berhad Announces Cessation of GOH CHONG CHUANG as Independent and Non Executive Chairman of Nomination Committee

We Think K-One Technology Berhad (KLSE:K1) Can Easily Afford To Drive Business Growth

Full year 2022 earnings released: EPS: RM0 (vs RM0.003 loss in FY 2021)

Third quarter 2022 earnings released: EPS: RM0.002 (vs RM0.003 loss in 3Q 2021)

Insufficient new directors

We're Not Very Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Rate

Medical Device Authority of Malaysia Grants Approval to K-One Meditech Sdn Bhd to Distribute Silicone Adhesive Tape Primarily Used for Wound Care Dressing

K-One Technology Berhad Provides Impairment of Plant and Equipment for the Second Quarter Ended June 30, 2022

Second quarter 2022 earnings released: RM0.003 loss per share (vs RM0.002 profit in 2Q 2021)

Medical Device Authority (MDA) of Malaysia Approves COVID-19 Antigen Self-Test Kit (Saliva) for Distribution by K-One MediTech Sdn Bhd

K-One Technology Berhad Announces the Appointment of Independent and Non Executive Member of Audit Committee

Here's Why We're Not Too Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Situation

First quarter 2022 earnings released: EPS: RM0.001 (vs RM0.001 in 1Q 2021)

Insufficient new directors

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

We're Not Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

We're Hopeful That K-One Technology Berhad (KLSE:K1) Will Use Its Cash Wisely

Second quarter 2021 earnings released: EPS RM0.002 (vs RM0.004 loss in 2Q 2020)

K-One Technology Berhad Announces Approval of Low Dead Volume Syringes Suitable for Covid-19 Vaccination by Medical Device Authority, Malaysia

Full year 2020 earnings released: RM0.012 loss per share (vs RM0.008 profit in FY 2019)

New 90-day low: RM0.30

Full year 2020 earnings released: RM0.012 loss per share (vs RM0.008 profit in FY 2019)

New 90-day low: RM0.33

Is K-One Technology Berhad's (KLSE:K1) Share Price Gain Of 115% Well Earned?

New 90-day low: RM0.33

Key Things To Understand About K-One Technology Berhad's (KLSE:K1) CEO Pay Cheque

Third quarter 2020 earnings released: EPS RM0.001

G-AsiaPacific (S) Pte Ltd Enters into an Agreement to Provide Amazon Web Services Cloud Services

New 90-day low: RM0.34

K-One Meditech Sdn Bhd Signs License Agreement with Star Syringe, Uk to Manufacture Syringe Safety Needle Cap in Malaysia & Distribute Worldwide

New 90-day low: RM0.35

New 90-day low - RM0.37

First half earnings released

New 90-day high - RM0.59

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane